Novavax's 15min chart shows RSI overbought, Bollinger Bands narrowing.

Novavax's 15-minute chart has triggered an overbought RSI and narrowing Bollinger Bands as of August 26, 2025 at 15:30. This suggests that the stock price has experienced a rapid ascent, potentially exceeding its fundamental support levels. Furthermore, the magnitude of the stock price fluctuations has decreased, indicating a possible loss of momentum.

Analysts have been closely scrutinizing several key companies in the financial and technology sectors, providing a mix of upgrades and downgrades. Nu Holdings, Applied Materials, Oklo Inc., Novavax, and Snowflake are among the companies receiving attention.

Gustavo Schroden from Citi Research upgraded Nu Holdings to 'Buy' with a target price of $18 [1]. Schroden highlighted the bank's ability to navigate and accelerate in key portfolios while maintaining solid asset quality. The stock has shown resilience despite economic and political headwinds in Latin America, and analysts expect continued growth in the coming years.

Louis Miscioscia at Daiwa Capital Markets downgraded Applied Materials from 'Outperform' to 'Hold'. The downgrade was due to slower demand from China and weaker-than-expected leading-edge demand [3]. The company's reliance on Chinese customers poses a significant risk, particularly with geopolitical tensions and regulatory uncertainties.

Oklo Inc. was initiated with a 'Hold' rating and a target price of $65. Analyst Jon Windham highlighted the company's potential for a broader U.S. nuclear infrastructure build-out [2]. Oklo's focus on sustainable energy solutions positions it as a potential player in the growing nuclear sector.

Novavax was downgraded to 'Sell' by Alec Stranahan, citing the company's uncertain growth outlook and challenges in commercializing the Nuvaxovid COVID-19 vaccine [2]. Stranahan's assessment underscores the challenges faced by the company in its efforts to expand its market presence.

The current market conditions and analyst ratings provide valuable insights for investors. While some companies are expected to perform well, others face significant challenges. It is essential for investors to conduct thorough research and consider their risk tolerance when making investment decisions.

References:
[1] https://www.ainvest.com/news/analysts-picks-nu-holdings-applied-materials-oklo-novavax-snowflake-2508/
[2] https://www.investing.com/news/analyst-ratings/rothschild-redburn-reiterates-buy-rating-on-nu-holdings-stock-at-18-93CH-4203591
[3] https://www.forbes.com/sites/greatspeculations/2025/08/22/buy-sell-or-hold-applied-materials-stock/